EAS Advanced Course in Clinical Lipidology 

Milan, April 14-15, 2010

Programme: DAY 1

Module 1

09:00-11:00
Interactive Seminars
(20 min plus 10 min discussion)

 
  • LDL and the atherosclerotic plaque: a causal connection 
  • Elevated TG and VLDL remnants: a role in CVD?
  • Lp(a):  a controversy resolved?
  • HDL particle dysfunction in cardiometabolic disease: therapeutic impilcations

11:00-12:30
Clinical Rounds, Part I

 During the Course delegates will take part in three Clinical Rounds sessions, and for this they will be divided into three groups. Each group will take one round per session focussing on one of the topics below: 
  • (i) Familial hypercholesterolemia, (ii) diabetic dyslipidemia,
    (iii) stable CHD 
  • Imaging (intima-media thickness, endothelial reactivity, body-fat distribution, etc.)
  • Genetic screening and lipid biomarkers

Module 2
13:30-16.00
Interactive Seminars
(20 min plus 10 min discussion)
  • Genetic dyslipidemias: diagnosis and therapy 
  • Detecting subclinical atherosclerosis: does it help to better stratify the global cardiovascular risk of patients?
  • Secondary dyslipidemias: an underestimated issue in clinical practice 
  • Lifestyle measures and alternative therapies: do they impact CVD?

16:00-17:30
Clinical Rounds, Part II

 See Clinical Rounds, Part I. The groups each take rounds on a second topic.
 

DAY 2

Module 3

09:00-11:00
Interactive Seminars
(20 min plus 10 min discussion)
  • Pharmacological treatment of dyslipidemias: can clinical trial findings be reproduced in clinical practice?
  • Pharmacogenomics: implications for personalised therapy
  • Follow up of drug treatment and patient compliance: should we care? 
  • Pharmacoeconomic implications of lipid-lowering therapies

11:00-13.00
Clinical Rounds, Part III
and Case Study

See Clinical Rounds, Part I. The groups each take rounds on their third and final topic.

14:00-14:45
Q&A
  • Lipid-modulating therapies in high risk patients: what does the future hold?

 Module 4

14:45-15:30
  • Feedback from delegates
  • Closing remarks 
  • End of course